Heating tumors to the boiling point

December 05, 2000

Phase II kidney cancer trial demonstrates efficacy

CLEVELAND: Preliminary results from a Phase II study presented last week at the Radiological Society of North America meeting in Chicago demonstrate the effectiveness of non-surgical radiologic intervention using heat in the treatment of kidney cancers. Under MRI-guidance, which facilitates the placement of the probe and assures the complete destruction of the tumor mass, Dr. Jonathan Lewin has successfully "ablated" tumors in six patients, who have since had no recurrence of their disease.

Dr. Lewin has extensive experience through Phase I and now Phase II trials using radiofrequency ablation to heat tumors to a boiling point, using a needle that is directed into the tumor under magnetic resonance imaging (MRI) guidance. This procedure is done in a non-surgical setting, and the kidney cancer patients treated have all been poor surgical candidates (either because of age or other health issues). In this kind of cancer, you would normally see a recurrence within three to six months--but all of the patients being reported on are beyond that time period with no recurrence. Treatment was successful after only one session with RF ablation (the MRI guidance makes it possible to "see" the edges of the disease and destroy the entire tumor--temperature and tissue coagulation is visualized under MRI, achieving greater accuracy than ultrasound or CT imaging).

According to Dr.Lewin, the preliminary analysis shows that for small tumors (3 cm. or less), this approach is likely to result in the complete eradication of the cancer and the procedure is well-tolerated by patients. No patient has had to take more than Tylenol for post-procedure pain. Dr. Lewin is one of the nation's leading experts in interventional radiology, and has helped develop some of the tools required for use with magnetic resonance imaging. For several years, he has combined radiofrequency ablation techniques with MRI to eradicate kidney tumors. Using open MRI, which provides more comfortable surroundings to patients, doctors gain access to these abnormalities through a needle puncture. Using specially-designed titanium or stainless steel instruments which are not magnetic, doctors are guided by the MRI image to the site of the malignancy. They guide a titanium electrode (developed by Radionics of Burlington, Mass.) to the tumor and generate enough heat (just below the boiling point) to destroy the cancer cells.

"What used to be a bright white area of tumor becomes black, essentially a black hole of dead tumor tissue," says Dr. Lewin. "You can immediately see through the MRI image how much of the tumor is destroyed, how much is left, and how much further you need to go to completely eradicate the cancer." There is also no cumulative dose effect, as there is in radiation therapy, so patients can be treated repeatedly if the cancer returns to other sites.
University Hospitals Health System (UHHS) is the region's premier healthcare delivery system, serving patients at more than 120 locations throughout northern Ohio.

Committed to advanced care and advanced caring, University Hospitals Health System offers the region's largest network of primary care physicians, outpatient centers and hospitals. The System also includes a network of specialty care physicians, skilled nursing, elder health, rehabilitation and home care services, managed care and insurance programs, and the most comprehensive behavioral health services in the region.

The System's 947-bed, tertiary medical center, University Hospitals of Cleveland (UHC), is the primary affiliate of Case Western Reserve University. Together, they form the largest center for biomedical research in the State of Ohio. Included in UHC are Rainbow Babies & Children's Hospital, among the nation's best children's hospitals; Ireland Cancer Center, northern Ohio's only National Cancer Institute-designated Comprehensive Cancer Center (the nation's highest designation); and MacDonald Women's Hospital, Ohio's only hospital for women.

University Hospitals of Cleveland

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.